Found 38 matching trials
Libyan Multiple Sclerosis Registry Study N/A This study aims to understand differences in access to diagnosis and treatm...
Show More Location
Tripoli University Hospital
Learn More & Join Trial
Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) PHASE4 The purpose of this study was to understand whether participants could moun...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) PHASE2 The primary objective of Part 1 of this study is to evaluate the effects of...
Show More Learn More & Join Trial
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate) N/A The primary objectives of the study are to estimate the risk of major conge...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
Pediatric Spinal Muscular Atrophy (SMA) China Registry N/A The primary objective of the study is to describe the natural history and u...
Show More Status
Active Not Recruiting
Location
Anhui Children's Hospital
Learn More & Join Trial
A Real-world Study of Disease-modifying Therapy Treatment Outcomes in Patients With Spinal Muscular Atrophy N/A The aim of this study was to evaluate treatment patterns, SMA-related compl...
Show More Learn More & Join Trial
A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis PHASE2 This multicenter, randomized, open-label clinical trial aims to evaluate th...
Show More Location
Multiple Locations
Learn More & Join Trial
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study N/A The primary objective of this study is to document immunization status of M...
Show More Location
Multiple Sklerose Zentrum
Learn More & Join Trial
A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis PHASE4 The purpose of this study is to evaluate the change in patient-reported out...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis PHASE4 In this prospective, open-label, single-arm, single-institution trial, the ...
Show More Location
Northwestern Memorial Hospital
Learn More & Join Trial